These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2014215)

  • 1. The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.
    Frijlink HW; Eissens AC; Hefting NR; Poelstra K; Lerk CF; Meijer DK
    Pharm Res; 1991 Jan; 8(1):9-16. PubMed ID: 2014215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.
    Frijlink HW; Franssen EJ; Eissens AC; Oosting R; Lerk CF; Meijer DK
    Pharm Res; 1991 Mar; 8(3):380-4. PubMed ID: 2052529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.
    Pitha J; Gerloczy A; Olivi A
    J Pharm Sci; 1994 Jun; 83(6):833-7. PubMed ID: 9120816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat.
    Frijlink HW; Visser J; Hefting NR; Oosting R; Meijer DK; Lerk CF
    Pharm Res; 1990 Dec; 7(12):1248-52. PubMed ID: 2095562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of parenteral hydroxypropyl beta-cyclodextrin.
    Carpenter TO; Gerloczy A; Pitha J
    J Pharm Sci; 1995 Feb; 84(2):222-5. PubMed ID: 7738806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans.
    Irie T; Fukunaga K; Garwood MK; Carpenter TO; Pitha J; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):524-8. PubMed ID: 1522488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
    McCormack B; Gregoriadis G
    Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.
    Irie T; Fukunaga K; Pitha J
    J Pharm Sci; 1992 Jun; 81(6):521-3. PubMed ID: 1522487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats.
    Gerloczy A; Hoshino T; Pitha J
    J Pharm Sci; 1994 Feb; 83(2):193-6. PubMed ID: 8169787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of 2-hydroxypropyl-beta-cyclodextrin in the assay of acyl-CoA:cholesterol acyltransferase and neutral and acid cholesterol ester hydrolases.
    Liza M; Romero JR; Chico Y; Fresnedo O; Ochoa B
    Lipids; 1996 Mar; 31(3):323-9. PubMed ID: 8900462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin (CD) complexes of cholesterol--their potential use in reducing dietary cholesterol intake.
    Somogyi G; Posta J; Buris L; Varga M
    Pharmazie; 2006 Feb; 61(2):154-6. PubMed ID: 16526565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cyclodextrins for manipulating cellular cholesterol content.
    Christian AE; Haynes MP; Phillips MC; Rothblat GH
    J Lipid Res; 1997 Nov; 38(11):2264-72. PubMed ID: 9392424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxypropyl-beta-cyclodextrin can modulate the activity of spinally administered sufentanil.
    Meert TF; Mesens J; Verheyen P; Noorduin H
    Eur J Anaesthesiol; 1992 Sep; 9(5):399-409. PubMed ID: 1396627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional effects of cyclodextrins on liver and serum lipids and cecal organic acids in rats.
    Kaewprasert S; Okada M; Aoyama Y
    J Nutr Sci Vitaminol (Tokyo); 2001 Oct; 47(5):335-9. PubMed ID: 11814148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of beta-cyclodextrin derivatives on alpha-chymotryptic degradation and enteral absorption of insulin in rats.
    Shao Z; Li Y; Chermak T; Mitra AK
    Pharm Res; 1994 Aug; 11(8):1174-9. PubMed ID: 7971720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
    Arima H; Adachi H; Irie T; Uekama K; Pitha J
    Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydroxypropyl-beta-cyclodextrin on the antimicrobial action of preservatives.
    Lehner SJ; Müller BW; Seydel JK
    J Pharm Pharmacol; 1994 Mar; 46(3):186-91. PubMed ID: 8027925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel β-cyclodextrin derivatives.
    Wang H; Xie X; Zhang F; Zhou Q; Tao Q; Zou Y; Chen C; Zhou C; Yu S
    Food Chem Toxicol; 2011 Jun; 49(6):1387-93. PubMed ID: 21426923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
    Löscher W; Hönack D; Richter A; Schulz HU; Schürer M; Düsing R; Brewster ME
    Epilepsia; 1995 Mar; 36(3):255-61. PubMed ID: 7614909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.